Dihashita Tablets 50/1000 mg
Sitagliptin Phosphate Hydrate · Metformin Hydrochloride
Prescription medication · Combination
(Co., Ltd.) AProgen Biologics
MFDS item code 201506652 · Approved 2015.09.21
This product's status changed to Approval withdrawn on 2023.08.23. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of blood sugar control in type 2 diabetes
This drug is used in conjunction with dietary and exercise therapies to help control blood sugar in patients with type 2 diabetes. If blood sugar control is difficult and there is no previous experience with diabetes medication, it may be used alone. It can also be used as an alternative when monotherapy with metformin or sitagliptin is insufficient, or in combination with both drugs. This drug will be added to combination therapy when blood sugar control is difficult with metformin combined with sulfonylureas or thiazolidinediones. It is also used in combination with insulin and metformin if blood sugar control is insufficient. Therefore, this drug is used to improve blood sugar control in various cases of patients with type 2 diabetes.
This drug is generally taken twice a day with food, and the dosage is gradually increased to reduce gastrointestinal adverse effects caused by metformin. 1. Patients not currently being treated with metformin: Take this drug 50/500 mg twice a day, 1 tablet per dose, and it may be increased to 50/1000 mg. 2. Patients already being treated with metformin: Sitagliptin 50 mg once a day
This drug contains sitagliptin and metformin, antidiabetic agents that help control blood sugar. While taking this drug, serious allergic reactions may occur, so if symptoms such as skin rash, difficulty breathing, or swelling of the face or neck appear, stop taking the drug immediately and consult a physician. There is a risk of pancreatitis, which is inflammation of the pancreas, so if symptoms such as abdominal pain, nausea, vomiting, or fever occur, notify healthcare professionals immediately. This drug should not be administered to patients with severely impaired kidney function or patients with acute diseases such as severe infections, dehydration, or acute myocardial infarction. Before undergoing tests using radiocontrast iodine agents, this drug should be temporarily discontinued, and it should be resumed only after confirming that kidney function is normal post-examination. It is safe for pregnant or breastfeeding women not to take this drug. This drug may cause hypoglycemia, so when taken with other hypoglycemic agents, blood sugar levels should be checked frequently, and attention should be paid to symptoms of hypoglycemia. Maintain regular meals and adequate exercise while taking this medication, and have regular kidney function and blood tests. Alcohol consumption may increase the risk of lactic acidosis, so it is advisable to avoid drinking alcohol while on this medication. If oral intake is difficult due to surgery or serious illness, this drug should be temporarily discontinued, and it can be restarted once the condition improves. Gastrointestinal side effects such as diarrhea, nausea, or headache may occur during the use of this drug, and if symptoms are severe, consult healthcare professionals. Elderly patients are at risk of reduced kidney function, so they should have frequent kidney function tests before and during treatment, and dosage adjustments may be necessary. In case of an overdose of this drug, immediately visit a healthcare facility for appropriate treatment, as some components can be removed by dialysis. There may be drug interactions, so if there are other medications being taken, it is essential to inform the healthcare provider, especially when combined with drugs affecting kidney function. If there are unusual symptoms or discomfort while taking this drug, it is important to consult healthcare professionals immediately.
Not everyone experiences these, and they can vary from person to person.
Store this drug in a tightly closed container to prevent air or moisture from entering, and it is advisable to keep it at room temperature between 1 degree and 30 degrees Celsius.
Dark red oval film-coated tablets
28 tablets/PTP, 56 tablets/PTP
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Sitagliptin Phosphate Hydrate · Metformin Hydrochloride
Prescription medication · Combination
(Co., Ltd.) AProgen Biologics
CombinationSitagliptin Phosphate Hydrate 64.25mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Jongkun Dang Co., Ltd.
CombinationSitagliptin Phosphate Hydrate 64.25mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationSitagliptin Phosphate Hydrate 64.25mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationMetformin Hydrochloride 500mg · Sitagliptin Phosphate Hydrate 64.25mg
Tablet · Prescription medication · Combination
Jong Kun Dang Co., Ltd.
CombinationMetformin Hydrochloride 1000mg · Sitagliptin Phosphate Hydrate 64.25mg
Tablet · Prescription medication · Combination
JongKeunDang Co., Ltd.
CombinationMetformin Hydrochloride 1000mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
Sitagliptin Phosphate 62.04mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Yuyu Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.